1) Bahar I, Loya N, Weinberger D, Avisar R. Effect of pterygium surgery on corneal topography: a prospective study. Cornea 2004;23:113-7.
4) Zauberman H. Pterygium and its recurrence. Am J Ophthalmol 1967;63:1780-6.
7) Han SB, Yang HK, Hyon JY, Wee WR. Conjunctival metaplasia after pterygium excision and limbal autograft. Optom Vis Sci 2015;92:324-8.
9) Frau E, Labétoulle M, Lautier-Frau M, Hutchinson S, Offret H. Corneo-conjunctival autograft transplantation for pterygium surgery. Acta Ophthalmol Scand 2004;82:59-63.
10) Al Fayez MF. Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 2002;109:1752-5.
11) Miyai T, Hara R, Nejima R, Miyata K, Yonemura T, Amano S. Limbal allograft, amniotic membrane transplantation, and intraoperative mitomycin C for recurrent pterygium. Ophthalmology 2005;112:1263-7.
14) Hirst LW. Prospective study of primary pterygium surgery using pterygium extended removal followed by extended conjunctival transplantation. Ophthalmology 2008;115:1663-72.
15) Shimazaki J, Kosaka K, Shimmura S, Tsubota K. Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 2003;110:119-24.
16) Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 2004;23:458-63.
18) Han SB, Jeon HS, Kim M, et al. Risk factors for recurrence after pterygium surgery: an image analysis study. Cornea 2016;35:1097-103.
19) Han SB, Jeon HS, Kim M, et al. Quantification of Astigmatism induced by pterygium using automated image analysis. Cornea 2016;35:370-6.
23) Khalfaoui T, Mkannez G, Colin D, et al. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients. Pathol Biol (Paris) 2011;59:137-41.
24) Teng CC, Patel NN, Jacobson L. Effect of subconjunctival bevacizumab on primary pterygium. Cornea 2009;28:468-70.
25) Shenasi A, Mousavi F, Shoa-Ahari S, Rahimi-Ardabili B, Fouladi RF. Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial. Cornea 2011;30:1219-22.
26) Shahin MM, Elbendary AM, Elwan MM. Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report. Ophthalmic Surg Lasers Imaging 2012;43:459-66.
27) Nava-Castañeda A, Olvera-Morales O, Ramos-Castellon C, Garnica-Hayashi L, Garfias Y. Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up. Clin Exp Ophthalmol 2014;42:235-41.
30) Zhang X, Jiang Y, Fu Q, Zhang X, Chen Y. Efficacy of bevacizumab in the treatment of pterygium: An updated meta-analysis of randomized controlled trials. Int Immunopharmacol 2021;98:107921.
31) Tan DT, Liu YP, Sun L. Flow cytometry measurements of DNA content in primary and recurrent pterygia. Invest Ophthalmol Vis Sci 2000;41:1684-6.
32) Colombres GA, Gramajo AL, Arrambide MP, et al. Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study. J Ophthalmic Vis Res 2011;6:18-25.